Compare CRVO & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVO | PLSM |
|---|---|---|
| Founded | 2001 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 38.5M |
| IPO Year | 2011 | N/A |
| Metric | CRVO | PLSM |
|---|---|---|
| Price | $4.01 | $3.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 106.4K | 5.0K |
| Earning Date | 03-17-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,006,510.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.58 | $3.70 |
| 52 Week High | $14.97 | $6.85 |
| Indicator | CRVO | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 38.41 | 35.35 |
| Support Level | $3.58 | $3.70 |
| Resistance Level | $5.38 | $5.19 |
| Average True Range (ATR) | 0.48 | 0.35 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 14.09 | 38.46 |
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Pulsenmore Ltd is engaged in developing portable ultrasound devices for home use. Its ultrasound scanner dock's with patients' smartphones to deliver images that can be created anywhere, stored and forwarded for clinical review, or shared in an online consultation.